Literature DB >> 2551316

Binding characteristics reveal partial GABA agonist activities of SR 95531.

L N Zimmermann1, H H Schneider, D N Stephens.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2551316     DOI： 10.1007/BF01674276

Source DB:  PubMed          Journal:  J Protein Chem        ISSN： 0277-8033


× No keyword cloud information.
  7 in total

1.  GABAergic modulation of benzodiazepine binding site sensitivity.

Authors:  J F Tallman; J W Thomas; D W Gallager
Journal:  Nature       Date:  1978-07-27       Impact factor: 49.962

2.  Biochemical characterization of the interaction of three pyridazinyl-GABA derivatives with the GABAA receptor site.

Authors:  M Heaulme; J P Chambon; R Leyris; J C Molimard; C G Wermuth; K Biziere
Journal:  Brain Res       Date:  1986-10-08       Impact factor: 3.252

3.  GABAA receptor blockers reverse the inhibitory effect of GABA on brain-specific [35S]TBPS binding.

Authors:  R F Squires; E Saederup
Journal:  Brain Res       Date:  1987-06-30       Impact factor: 3.252

4.  [35S]-t-butylbicyclophosphorothionate binding sites are constituents of the gamma-aminobutyric acid benzodiazepine receptor complex.

Authors:  P Supavilai; M Karobath
Journal:  J Neurosci       Date:  1984-05       Impact factor: 6.167

5.  The effect of temperature and chloride ions on the stimulation of [3H]flunitrazepam binding by the muscimol analogues THIP and piperidine-4-sulfonic acid.

Authors:  P Supavilai; M Karobath
Journal:  Neurosci Lett       Date:  1980-10-02       Impact factor: 3.046

6.  Quantitative evaluation of the properties of a pyridazinyl GABA derivative (SR 95531) as a GABAA competitive antagonist. An electrophysiological approach.

Authors:  M Hamann; M Desarmenien; E Desaulles; M F Bader; P Feltz
Journal:  Brain Res       Date:  1988-03-01       Impact factor: 3.252

7.  Binding of 3H-DMCM to benzodiazepine receptors; chloride dependent allosteric regulation mechanisms.

Authors:  T Honoré; M Nielsen; C Braestrup
Journal:  J Neural Transm       Date:  1983       Impact factor: 3.575
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.